科室与专家门诊

妙佑医疗国际是美国规模最大、经验最丰富的医疗机构之一,在亚利桑那州、佛罗里达州和明尼苏达州都设有院区。我们的工作人员涉及数十种专业,通过齐心协力确保高品质治疗与成功康复。

行此手术的医生

编辑搜索过滤条件
close

缩小搜索范围

  1. 未找到姓氏以该字母开头的医生 A
  2. 未找到姓氏以该字母开头的医生 B
  3. 未找到姓氏以该字母开头的医生 C
  4. 未找到姓氏以该字母开头的医生 D
  5. 未找到姓氏以该字母开头的医生 E
  6. 查找姓氏以该字母开头的医生 F
  7. 未找到姓氏以该字母开头的医生 G
  8. 未找到姓氏以该字母开头的医生 H
  9. 未找到姓氏以该字母开头的医生 I
  10. 未找到姓氏以该字母开头的医生 J
  11. 查找姓氏以该字母开头的医生 K
  12. 未找到姓氏以该字母开头的医生 L
  13. 未找到姓氏以该字母开头的医生 M
  14. 未找到姓氏以该字母开头的医生 N
  15. 未找到姓氏以该字母开头的医生 O
  16. 查找姓氏以该字母开头的医生 P
  17. 未找到姓氏以该字母开头的医生 Q
  18. 主动 查找姓氏以该字母开头的医生 R
  19. 查找姓氏以该字母开头的医生 S
  20. 查找姓氏以该字母开头的医生 T
  21. 未找到姓氏以该字母开头的医生 U
  22. 未找到姓氏以该字母开头的医生 V
  23. 查找姓氏以该字母开头的医生 W
  24. 未找到姓氏以该字母开头的医生 X
  25. 未找到姓氏以该字母开头的医生 Y
  26. 未找到姓氏以该字母开头的医生 Z
重置所有过滤器

显示$起始范围 - $结束范围/源自可用$可用医生

姓氏首字母: R

  1. Kunam S. Reddy, M.B.B.S., M.D.

    Kunam S. Reddy, M.B.B.S., M.D.

    1. General Surgeon
    2. Transplant Surgeon
    1. Phoenix, AZ
    擅长领域:

    Pancreas transplant, Liver transplant, Living donor liver transplant, Whipple procedure, Kidney transplant, Living dono...r kidney transplant, Deceased donor kidney transplant, Immunosuppressive drug therapy, Portal hypertension

研究

诊断放射科医生

诊断放射专科医生研究使用先进的高分辨率成像(如 PET MRI)来护理接受惠普尔手术的患者的新方法。

妙佑医疗国际外科医生研发出全新的治疗方案,使惠普尔手术成为更多患者的选择,同时提高了这一群体的生存率。

由于越来越多的患者在惠普尔手术后得以延长生存期,妙佑医疗国际的研究人员正在研究如何提高术后的生活质量。

此外,妙佑医疗国际胃肠道癌项目积极研究胰腺癌的新诊断工具、治疗方案和预防方法。参加项目的妙佑医疗国际医生致力于进一步探索累及肠道的癌症科学知识,努力改善受累患者的生活质量。

文献

请参阅美国国家医学图书馆检索服务系统 PubMed 所收录的妙佑医疗国际医生在胰腺癌领域的文献目录。

Research Profiles

June 14, 2024
  1. Delaney CP. Pancreaticoduodenectomy. In: Netter's Surgical Anatomy and Approaches. 2nd ed. Elsevier; 2021. https://www.clinicalkey.com. Accessed March 24, 2023.
  2. Townsend CM Jr, et al. Exocrine pancreas. In: Sabiston Textbook of Surgery: The Biological Basis of Modern Surgical Practice. 21st ed. Elsevier; 2022. https://www.clinicalkey.com. Accessed March 24, 2023.
  3. Reber HA. Surgical resection of lesions of the head of the pancreas. https://www.uptodate.com/contents/search. Accessed March 24, 2023.
  4. Mantzavinou A, et al. Robotic versus open pancreaticoduodenectomy, comparing therapeutic indexes; a systematic review. International Journal of Surgery. 2022; doi:10.1016/j.ijsu.2022.106633.
  5. Simon R. Complications after pancreaticoduodenectomy. Surgical Clinics of North America. 2021; doi:10.1016/j.suc.2021.06.011.
  6. Riggin EA. Allscripts EPSi. Mayo Clinic. Feb. 9, 2017.
  7. Truty MJ (expert opinion). Mayo Clinic. Feb. 22, 2017.
  8. Fernandez-del Castillo C, et al. Overview of surgery in the treatment of exocrine pancreatic cancer and prognosis. https://www.uptodate.com/contents/search. Accessed March 24, 2023.
  9. Bergquist JR, et al. Implications of CA19-9 elevation for survival, staging and treatment sequencing in intrahepatic cholangiocarcinoma: A national cohort analysis. Journal of Surgical Oncology. 2016; doi:10.1002/jso.24381.
  10. Katz MHG, et al. Preoperative modified FOLFIRINOX treatment followed by Capecitabine-based chemoradiation for borderline resectable pancreatic cancer: Alliance for Clinical Trials in Oncology Trial A021101. JAMA Surgery. 2016; doi:10.1001/jamasurg.2016.
  11. Shubert CR, et al. Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant chemotherapy: An intention to treat analysis of the National Cancer Database. Surgery. 2016; doi:10.1016/j.surg.2016.06.010.
  12. Bergquist JR, et al. Risk by indication for pancreaticoduodenectomy in patients 80 years and older: A study from the American College of Surgeons National Surgical Quality Improvement Program. HPB. 2016; doi:10.1016/j.hpb.2016.07.012.